Wet Heparinized Suction for Abdominal Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorH. Lee Moffitt Cancer Center and Research Institute
About this trial
The purpose of this research is to compare the amount and quality of tissue obtained by EUS-FNB when the device is flushed with an anticoagulant or "blood thinner" vs. saline a salt water solution as well as the use of a microsieve in order for the doctor to look at the tissue to check the acceptability of the specimens before sending for analysis.
You will be randomly assigned (like a flip of a coin) to have either the blood thinner or the salt water solution placed within the needle being used to sample your abdominal tumor and to have either a sieve used or not.
You will be one of 42 participants enrolled in this data collection study which includes 1 sites in the United States.
Eligibility criteria
Qualifiers
Age ≥ 18 year
Non-pregnant Patients
Patients with the presence of a solid abdominal mass as seen on diagnostic imaging [ie. ultrasound (US), computer tomography (CT) or magnetic resonance imaging (MRI)] scheduled to undergo EUS examination OR Patients who underwent a prior EUS-FNA/FNB for solid pancreatic mass and did not receive a conclusive diagnosis
Patients with platelet count > 50,000
Disqualifiers
Age < 18 years
Pregnant Patients
Patients who cannot consent for themselves
Patients with anticoagulants or anti-platelet agents (excluding aspirin) within the last 7-10 days
Trial design
Treatments tested in this trial
- wet heparinzed suction
- Microsieve
- No heparin flush
- No microsieve
Treatment groups
42 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov